New Key Statistics Module, Z-Score and F-Score
NAS:ZNTL Key Ratios
| Market Cap $ M | 754.16 |
| Enterprise Value $ M | 307.79 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.64 |
| Price/Sales | 18.63 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 40.00 |
| EPS (TTM) $ | -3.33 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -28.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.44 |
| EV-to-EBITDA | -1.45 |
| PEG | -- |
| Shares Outstanding M | 71.01 |
| Net Margin (%) | -539.70 |
| Operating Margin % | -527.00 |
| Pre-tax Margin (%) | -507.56 |
| Quick Ratio | 9.19 |
| Current Ratio | 9.19 |
| ROA % (ttm) | -39.01 |
| ROE % (ttm) | -47.87 |
| ROIC % (ttm) | -349.38 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.20 |
ZNTL Number of Guru Trades
ZNTL Volume of Guru Trades
Gurus Latest Trades with NAS:ZNTL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ZNTL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zentalis Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ZNTL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers